More EU Notified Bodies Bite The Dust
The number of notified bodies operating under the EU's current medical device directives continue to decline, and that trend is expected to persist with the new regulations entering into force. Here's a look at country-by-country trends in notified bodies operating under the three current medtech EU directives.
You may also be interested in...
As the date that EU notified bodies can submit for designation under the new regulations rapidly approaches, can EU designating authorities audit notified bodies against the MDR and IVDR at the same time to improve efficiency? And can notified bodies audit against the legacy directives alongside the regulations to minimize worst-case logjams?
Prepare for notified body bottlenecks and skyrocketing clinical evaluation costs for medical devices as you comply with the EU Medical Device Regulation (MDR): that's what German medtech industry delegates were told at a legal and regulatory symposium last week.
Second of two articles covering discussion at the spring 2017 meeting of the British In Vitro Diagnostics Association: Not all will survive unscathed as the EU IVD Regulation becomes an operational reality.